Sen. Markwayne Mullin bought Elevance Health (ELV)
Sen. Markwayne Mullin (R-OK) · $1K–$15K · traded Oct 3, 2023
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Oct 3, 2023
- Disclosed
- Nov 1, 2023
- Days to disclose
- 29
- Asset type
- Stock
- As filed
- Elevance Health, Inc. Common Stock
- Industry
- Medical - Healthcare Plans · Healthcare
Other trades in this filing
All of Mullin's trades →- Nov 1, 2023$50K–$100K
Bought Nevada St Ltd Tax Go Cap Impt BDS Rate/Coupon: 5.0% Matures: 05/01/38
$50K–$100K · Traded Oct 25, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$15K–$50K
Bought Tulsa County Oklahoma Indl Auth Edl Rate/Coupon: 5.0% Matures: 09/01/2027
$15K–$50K · Traded Oct 18, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$15K–$50K
Bought University Oklahoma Revs Rate/Coupon: 5.0% Matures: 07/01/2028
$15K–$50K · Traded Oct 17, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$250K–$500K
Bought Oklahoma Dev Fin Auth Health Rate/Coupon: 0.41% Matures: 08/15/2031
$250K–$500K · Traded Oct 13, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$50K–$100K
Bought POCONO MTN PA SCH DIST GO NTS 2023 Rate/Coupon: 4.5% Matures: 10/01/2026
$50K–$100K · Traded Oct 12, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$50K–$100K
$50K–$100K · Traded Oct 6, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$15K–$50K
Bought Purcell Oklahoma Public Works Auth Rate/Coupon: 5.0% Matures: 03/01/2030
$15K–$50K · Traded Oct 4, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$50K–$100K
Bought Kaukauna Wis Antic Nts 2023 B Rate/Coupon: 5.0% Matures: 06/01/28
$50K–$100K · Traded Oct 4, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$50K–$100K
$50K–$100K · Traded Oct 4, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
Bought American Express Company AXP
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
Bought Abbott Laboratories ABT
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
Bought Hilton Worldwide Holdings HLT
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
Bought The Sherwin-Williams Company SHW
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
Bought Berkshire Hathaway BRK-B
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
- Nov 1, 2023$1K–$15K
Bought Intercontinental Exchange ICE
$1K–$15K · Traded Oct 3, 2023 · disclosed Nov 1, 2023 · Joint
Recent Congress trades in ELV
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jan 16, 2026$15K–$50K
Sen. Markwayne Mullin (R-OK)
$15K–$50K · Traded Dec 29, 2025 · disclosed Jan 16, 2026 · Joint
- Sep 12, 2025$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Aug 26, 2025 · disclosed Sep 12, 2025 · Dependent
- Sep 12, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Aug 13, 2025 · disclosed Sep 12, 2025 · Spouse
- Sep 12, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Aug 5, 2025 · disclosed Sep 12, 2025
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Jan 13, 2025 · disclosed Sep 12, 2025 · Spouse · filed 242 days later
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Oct 29, 2024 · disclosed Sep 12, 2025 · Spouse · filed 318 days later
Company context for ELV
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
ELV: third_quarter 2026 lobbying report
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues surrounding risk adjustment. Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) Issues related to No Surprises Act implementation.
Public: Oct 20, 2026, 3:32 PM EDTOriginal source ↗ELV: third_quarter 2026 lobbying report
Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 7040) ACA Exchanges & Enrollment Enhanced Premium Tax Credits Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act) (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Health Care Price Certainty for All Americans Act (H.R. 9645) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Affairs Community Cares program The Take Care of Americas Veterans Act (H.R. 92
Public: Oct 20, 2026, 2:52 PM EDTOriginal source ↗ELV: third_quarter 2026 lobbying report
Federal budget issues Lobbying related to health care access, Medicare, and Medicaid policy Lobbying related to health care access Tax policy Lobbying related to health care access, Medicare, and Medicaid policy
Public: Oct 20, 2026, 2:24 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.